4D BIOMATERIALS SHOWCASING EXPERT DESIGN SERVICES
Medical polymer pioneer launches 4D Design™ Innovation Hub at Formnext 2022 to support commercial partners
Based at the company headquarters in Nottingham, UK, the 4D Design™ Innovation Hub brings together an experienced and passionate team of mechanical, design, and bioengineering experts with access to cutting-edge 3D CAD, simulation and analysis software, alongside macro and micro-scale 3D printing hardware for rapid prototype production.
Phil Smith, CEO, commented, “We are delighted to be back at Formnext this year as it represents an excellent opportunity for us to engage with key stakeholders in the additive manufacturing and medical device worlds. We have developed some strong industry relationships as a result of exhibiting here last year, and we are looking forward to sharing the latest exciting chapter in our commercial development story with attendees. The 4D Design™ Innovation Hub is a game-changer that will enable our partners to move quickly from ideation to prototype evaluation and beyond.”
4D Biomaterials’ commercial team will be available to discuss 4Degra® and the 4D Design™ Innovation Hub on Stand A39, Hall 11.1 at Formnext, Messe Frankfurt, Germany from Tuesday, November 15th, 2022 to Friday, November 18th, 2022.
4D Biomaterials is researching, developing, and commercialising a portfolio of degradable medical polymers based on proprietary photocurable polycarbonate urethane chemistry. These materials, marketed under the brand name 4Degra® can be processed using various SLA and DLP photocurable additive manufacturing technologies.
4D Biomaterials is a trading style of 4D Medicine Limited.
Phil Smith
4D Medicine Limited
+44 7891 140962
p.smith@4dbiomaterials.co.uk
4D Biomaterials video explainer
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

